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 ABSTRACT 
NIR Photothermal therapy has developed very quickly in recent years. 
However, its clinical applications are hindered by the many practical problems, 
such as low accumulation in tumor, high laser power density and high 
biotoxicity in vivo. Herein, a versatile system combining chemotherapy with 
photothermal therapy for cancer therapy using ultra-small Pd nanosheet 
(SPNS) was developed. The SPNS can serve as pH-responsive drug carriers to 
efficiently deliver DOX into cancer cell and tumor. On the other hand, the 
coordinative loading of DOX on SPNS enhances its accumulation in tumor 
tissue. So we can efficiently ablate tumor using low-intensity laser radiation. 
Importantly, with ultra-small size (~4.4 nm), the GSHylated SPNS can be 
cleared from body through the renal into urine. The cancer therapeutic 
nanosystem, which exhibit a significant synergistic effect and low systemic 




Photothermal therapy using NIR laser has recently 
emerged as a new candidate technique for cancer 
treatment [1-3].  This technique involves absorbing 
the visible and near-infrared (NIR) light and 
converting it into heat [4]. NIR light is highly 
desirable for in vivo imaging and therapeutic 
applications owing to the minimal optical absorption 
of blood and soft tissue in this region to allow the 
maximal tissue penetration [5]. Many NIR resonant 
nanomaterials such as Au nanoshells [6], Au 
nanorods [7], Au nanocages [8], graphene nanosheets 
[9, 10], carbon nanotubes [11, 12] and Pd nanosheets 
[13], have been widely studied, because these 
nanomaterials can strongly absorb NIR light and 
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Although significant progress has been made on 
the NIR photothermal therapy, there are still 
challenges to be addressed before its clinical 
applications [14-26]. For example, efficient area of the 
photothermal destruction of cancer cells is restricted 
by spot size of laser beam, resulting in a confined 
therapeutic area of cancer tissues. In many cases, 
relatively high laser power (e.g., 2-4 W/cm2 for gold 
nanomaterials) is required to obtain sufficient heat to 
kill cancer cells [27-32]. Moreover, NIR resonant 
nanomaterials may cause high toxicity due to their 
low-level renal clearance and nonspecific high 
accumulation in the organs of the reticuloendothelial 
system (RES) (e.g. liver, spleen) after systematic 
administration [33, 34]. 
We demonstrate in this work a multifunctional 
nanosystem integrating chemotherapy and 
photothermal therapy together to overcome several 
limitations of currently available NIR photothermal 
therapeutic systems as discussed above. The system 
is based on ultra-small Pd nanosheets (SPNS) 
functionalized with anticancer drug doxorubicin 
hydrochloride (DOX). SPNS have an average 
diameter of ~4.4 nm, and thus exhibit both high 
photothermal efficiency and optimal clearance 
characteristics. DOX molecules are loaded on SPNS 
mainly through Pd-N coordination bonding. After 
the SPNS-DOX hybrid nanoparticles are 
surface-functionalized with reduced glutathione 
(GSH), the obtained SPNS-DOX-GSH composite 
exhibits the following synergistic properties for 
cancer therapy: 1) The coordinative loading of DOX 
on SPNS enhances its accumulation in tumor tissue, 
significantly reducing the laser power required to 
achieve effective tumor ablation; 2) SPNS can 
serve as pH-responsive drug carriers to efficiently 
DOX delivery. More importantly, the size of 
SPNS-DOX-GSH is well below the renal filtration 
size, allowing the therapeutic agents to be effectively 
cleared from bodies.  
2 Experimental 
2.1 Synthesis of 4.4 nm Palladium Nanosheets 
Pd(II) acetylacetonate (Pd(acac)2, 10.0 mg), 
poly(vinylpyrrolidone) (PVP, MW=30000, 32.0 mg) 
and NaBr (30.6 mg) were mixed together with 
N,N-Dimethylpropionamide (2 mL) and water (4 
mL). After 10 hours on standing, the resulting 
homogeneous yellow solution was transferred to a 
glass pressure vessel. The vessel was then charged 
with CO to 1 bar and heated at 100 °C for 2 h before it 
was cooled to room temperature. The dark blue 
products were precipitated by acetone, separated via 
centrifugation and further purified by an 
ethanol-acetone mixture. 
2.2 The loading of DOX to Pd nanosheets 
0.5 mL solution of purified Pd nanosheets (200 μg 
mL-1) was mixed with 0.5 mL DOX (1 mg mL-1). The 
mixture was kept at 4 °C overnight before 
centrifugation. The particles were then washed with 
water at least 5 times and then dispersed in 5 mL 
RPMI 1640 culture medium.  
2.3 Cancer cells culture and their incubation with 
Pd nanosheets. 
Human hepatoma cells (QGY-7703) were cultured in 
RPMI 1640 medium in 24-well plates. The density 
was 1×105 cells/well. Before incubation with Pd 
nanosheets, the cells were seeded for 24 h. 0.5 mL of 
SPNS-DOX in culture medium were added to each 
well at a concentration of 20 μg mL-1. The incubations 
were carried out at 37 °C in 5% CO2 atmosphere for 
12 h. After incubation, the cell medium was removed, 
and the cells were washed before PBS buffer solution 
was added.   
2.4 Photothermal killing of cancer cells incubated 
with SPNS-DOX. 
After incubation with SPNS-DOX, human hepatoma 
cells were exposed to a 1.4 W cm-2 808-nm laser for 2 
min to induce photothermal cell damage. To identify 
the cell viability, the dead cells were stained with 
Trypan Blue.   
2.5 In Vivo Photothermal Destruction of Tumors. 
4T1 murine breast cancer cells (cell storeroom of 
Chinese Academy of Science) was cultured in RPMI 
1640 medium supplemented with 10% FBS and 1% 
penicillin/streptomycin (all reagents from Hyclone) 
under 5% CO2 atomosphere. The 4T1 cells (2×106 cells) 
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were harvested, suspended in 50 L PBS, and 
subcutaneously injected into the back of female 
Balb/c mice of each group (n=10). When the tumors 
were grown up to a volume of ~100 mm3, the mice of 
each group were intravenously injected with 200 L 
of each solution (1.5 mg mL-1 SPNS-GSH or 
SPNS-DOX-GSH solution, 0.085 mg mL-1 DOX 
solution, PBS) and irradiated with 0.3 W cm-2 
continuous NIR laser to tumor region for 5 min 24 h 
after injection. The tumor size of each group was 
measured using a skinfold caliper, and tumor 
volume was calculated using the following equation: 
tumor volume=ab2/2, where a is the maximum 
diameter of tumor and b is the minimum diameter of 
tumor. All studies on animals were done in 
accordance with the Guidelines for the Care and Use 
of Laboratory Animals in Fujian province, China.     
2.6 Urine Excretion of Pd nanosheets 
Male Sprague-Dawley rats (220 ± 30 g) were 
purchased from the Shanghai SLAC Laboratory 
Animal Co. Ltd. Rats were injected via the tail vein 
with 200 L of PBS containing 300 g of 
SPNS-DOX-GSH. Those rats were placed in 
stainless-steel metabolic cages and urine was 
collected. After collection of urine, samples of 1 mL 
digested by aqua regia and measured by ICP-MS. 
2.7 ICP-MS analysis 
Each tissue sample was completely digested by 2 mL 
of aqua regia at room temperature overnight. 
Subsequently, the solution was diluted to 10 mL 
using 0.5% HCl and 2% HNO3. Samples were passed 
through a 0.22-mm filter to remove any undigested 
debris prior, and then subjected to ICP-MS 
measurements. The analysis of Pd content was 
performed on ICP-MS (PerkinElmer DRC- Ⅱ ). 
Quantification was carried out by external five-point 
calibration with internal standard correction and the 
percentage of injected Pd dose per gram of tissue 
(%ID/g) was calculated. 
3 Results and discussion 
3.1 Characterization of SPNS-DOX  
To fabricate the SPNS-DOX nanoparticles, uniform 
SPNS with the average diameter of ~4.4 nm (Fig. 1(a)) 
were first prepared by reducing Pd(II) 
acectylacetonate using CO as both reducing and 
shaping controlling agents. The loading of DOX was 
then performed by dispersing and stirring the SPNS 
in a solution of DOX. The SPNS were able to load up 
to about 5.3% of DOX through Pd-N coordination 
bonding (Fig. S1 in the Electronic Supplementary 
Material (ESM)). Similarly to the Pd nanosheets, the 
as-prepared SPNS-DOX exhibits the strong surface 
plasmon resonance (SPR) absorption in the NIR 
region (Fig. 1(b)).  
 
Figure 1 Characterization and NIR photothermal properties of 
SPNS-DOX. (a) TEM image of the SPNS. Inset: diameter 
distribution of the SPNS. (b) Absorption spectrum of the DOX, 
SPNS and SPNS-DOX. (c) Photothermal effect of SPNS-DOX. 
The temperature versus time plots were recorded for various 
concentrations of SPNS-DOX upon irradiation by a 1-W laser. (d) 
Zeta potential distributions of original SPNS and SPNS-DOX in 
the PBS buffer (pH = 7.4). 
The photothermal effect of SPNS-DOX induced by 
the NIR SPR absorption was investigated by 
monitoring the temperature of 1 mL aqueous 
solutions of various concentration of SPNS-DOX (i.e., 
0, 7.5, 15 and 30 ppm Pd) irradiated by a NIR laser 
(808 nm, 1 W at 0.35 cm2). As shown in Fig. 1(c), the 
temperature of the SPNS-DOX solution containing 30 
ppm Pd was risen from 25.6 to 48.8 oC after 10 min 
irradiation. Most importantly, after coated with DOX, 
the charge of the Pd nanosheets at pH=7.4 was 
shifted from -17.7 mV to +7.9 mV (Fig. 1(d)). It is well 
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known that the positively charged nanomaterials are 
more prone than negatively charged one to be taken 
up by living cells. Our ICP-MS measurements did 
confirm the enhanced cellular uptake of SPNS by the 
DOX modification (Fig. S2 in the ESM). This suggests 
that compared to SPNS, the SPNS-DOX should 
exhibit not only chemotherapeutic but also enhanced 
photothermal efficacy of cancer cells killing.   
3.2 chemo-photothermal therapeutic efficacy of 
SPNS-DOX in vitro 
To examine the effect of DOX loading on the overall 
chemo-photothermal therapeutic efficacy of 
SPNS-DOX, we first investigated the anticancer 
performances of SPNS-DOX in vitro. Human 
hepatoma cells (QGY-7703) were plated in 24-well 
plate and then further incubated in the medium 
containing desired concentration SPNS-DOX or free 
DOX for 12 h for comparison studies. Owing to the 
fluorescence of DOX (Fig. S3 in the ESM), it was 
possible to use fluorescence signals to quantitatively 
determine the amount of drug in cells by flow 
cytometry. As clearly illustrated in Fig. 2(a), after 
being loading on Pd nanosheets, DOX could be 
delivered into cells more efficiently. Moreover, DOX 
was released from SPNS-DOX in a pH-dependent 
manner. The release rate of DOX increased 
significantly with decreased pH (Fig. 2(b)). 3.0%, 
17.0%, 42.8%, and 49.7% of the adsorbed DOX were 
released within 24 h in PBS buffer solutions of pH 7.4, 
6.6, 5.2, and 3.6, respectively. It well known that 
cancer cells usually have a lower pH than normal 
cells [35, 36]. So it was expected that SPNS-DOX 
should release DOX faster in hepatoma cells than in 
hepatocytes (QSG-7701). To verify such an 
expectation, both cells were incubated with medium 
contain different concentrations of SPNS-DOX for 12 
h. As shown in Fig. 2(c), SPNS-DOX indeed exhibits a 
higher cytotoxicity for hepatomas cells than 
hepatocytes as measured by standard MTT assay.   
More interestingly, compared to SPNS, SPNS-DOX 
exhibits an enhanced photothermal therapy efficacy 
as well. As discussed above, the positive charged 
nature of SPNS-DOX is expected to facilitate the 
cellular uptake of Pd nanosheets, which should 
significantly enhance their efficacy in photothermal 
therapy of cancer cells. In our studies, after 12h 
incubation with SPNS or SPNS-DOX, QGY-7703 cells 
were irradiated by 808-nm laser at 1.4 W cm-2 to 
evaluate their therapeutic efficacies. As illustrated in 
Fig. 2(d), 100% of the cells incubated with SPNS-DOX 
were killed after 2 min irradiation. In comparison, at 
the same condition only half of the cells were killed 
by the unmodified SPNS (Fig. S4 in the ESM). Less 
than 20% cancer cells were killed by chemotherapy of 
SPNS-DOX in 12h. We therefore consider the 
enhanced cell killing efficacy SPNS-DOX was mainly 
because of the enhanced photothermal therapy. 
 
Figure 2 Specific toxicity of SPNS-DOX for cancer cells and 
enhanced photothermal therapy in vitro. (a) Flow cytometric 
profiles of QSG-7703 cells after being incubated with free DOX 
and SPNS-DOX. (b) pH-dependent releasing kinetics of DOX 
from SPNS-DOX. (c) Viability of healthy liver cells (QSG-7701) 
and hepatoma cells (QGY-7703) incubated for 12 h with 
different-concentrations of SPNS-DOX. The cell viabilities were 
measured by standard MTT assay. (d) Micrographs of QGY-7703 
cells after 12 h incubation with SPNS-DOX and also 2 min 
irradiation of NIR laser (1.4 W cm-2, 808 nm).   
3.3 Blood circulation and biodistribution in vivo 
The excellent in vitro chemo-photothermal 
therapeutic performances of SPNS-DOX have 
motivated us to further evaluate their behaviours in 
in vivo anticancer therapies. According to our 
previous study, the surface modifation by reduced 
glutathione (GSH) not only contributes to rendering 
the nanoparticles with desired stealthiness to the 
reticuloendothelial system (RES) organs, but also 
contributes to clearance of nanoparticles out of body 
by renal excretion. To modify SPNS-DOX with GSH, 
 
www.theNanoResearch.com∣www.Springer.com/journal/12274 | Nano Research 
5 Nano Res.     
0.5 mL DMF solution of SPNS-DOX (5 mg mL-1) was 
added into 3 mL of GSH solution (1.0 mg mL-1). The 
mixture was then shaken for 12 h at room 
temperature. Both SPNS-DOX samples before and 
after GSHylation were well dispersed in whole fetal 
bovine serum (FBS) and displayed nearly identical 
UV-Vis absorption profiles (Fig. S5 in the ESM). 
 
Figure 3 Pharmacokinetics and biodistribution of 
SPNS-DOX-GSH were studied by ICP-MS. (a) The blood 
circulation curve of SPNS-DOX-GSH determined by 
measuring Pd ion concentration in the blood at different time 
points post injection. (b) Biodistribution of SPNS-DOX-GSH in 
mice each organ. The unit was a percentage of injected dose per 
gram tissue (% ID/g). Error bars were based on triplicated 
samples. 
In order to study the in vivo behaviors of 
SPNS-DOX-GSH, male Sprague-Dawley (SD) rats 
were first chosen as the animal model to study the 
blood circulation. After a surgical operation, 
SPNS-DOX-GSH at a dose of 1 mg kg-1 was infused 
via the jugular vein to three rats respectively [37]. 
Blood samples (approximately 0.4 mL) were drawn 
via the carotid artery at different time points after 
administration. The samples were then lysed by aqua 
regia and measured by inductively coupled plasma 
mass spectrometry (ICP-MS) to determine the Pd ion 
concentration in samples. The blood circulation curve 
showed that the pharmacokinetics of 
SPNS-DOX-GSH followed a two-compartment model 
with the first and second phase blood circulation 
half-lives of ~ 0.4 h and 1.5 h, respectively (Fig. 3(a)). 
To further investigate their biodistributions, the 
SPNS-DOX-GSH was injected into Balb/c mice 
bearing 4T1 tumors via tail vein. Mice were sacrificed 
at 1, 12 or 24 hours post injection (p.i.), and their 
major organs (n = 3 per group) were weighed and 
lysed by aqua regia. The obtained homogenized 
tissue lysates were diluted and measured by ICP-MS 
to quantitatively determine the Pd concentrations. 
Importantly, as shown in Fig. 3(b), a high tumor 
accumulation (~10% ID/g) was observed at 24h p.i.. 
In contrast, under the same operation condition, the 
accumulation of SPNS-GSH in tumor is ~6% ID/g 
(Fig. S6 in the ESM). These results indicated that 
DOX loading on SPNS-GSH was also beneficial to 
enhance accumulation of the photothermal agents in 
solid tumors.   
3.4 Photothermal effect of SPNS-DOX-GSH in vivo  
 
Figure 4 Photothermal effect in vivo. Infrared thermal imaging 
under the photothermal heating by 808-nm laser irradiation for 
different time periods in saline-injected (a), 
SPNS-GSH-injected (b) and SPNS-DOX-GSH-injected (c) 
tumor under 0.3 W cm-2 irradiation. 
Encouraged by the high accumulation of SPNS in 
tumors and their strong NIR optical absorption, we 
then investigated the in vivo photothermal effect of 
SPNS-DOX-GSH by using NIR laser. The 4T1 
tumor-bearing Balb/c mice were randomly divided 
into three groups (n = 3 per group) which were 
intravenously injected with 200 L of saline, 
SPNS-GSH and SPNS-DOX-GSH in PBS (1.5 mg 
mL-1), respectively. At 24-h p.i., the tumors were 
exposed to 808 nm laser at the density of 0.3 W cm-2 
for 5 min. An infrared camera was used to record the 
full-body thermographic images (Fig. 4) and the 
temperature profile (Fig. S7 in the ESM). Under the 
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irradiation, for a typical mouse injected with 
SPNS-DOX-GSH, the tumor surface temperature 
increased rapidly from 32oC to reach 58.5oC within 5 
min. In marked contrast, the tumor surface 
temperature of the groups injected with SPNS-GSH 
was increased to 47.0 oC at the same condition while 
the temperature for the one with saline was ramped 
to 35.8oC only. These results clearly demonstrated the 
enhanced accumulation of SPNS in tumors resulted 
from the DOX loading has dramatically improved 
the photothermal therapeutic efficacy of Pd 
nanosheets. Such an improvement allows the use of 
low-power NIR for the therapeutic purpose and thus 
makes the NIR photothermal therapy safer.  
3.5 Chemo-photothermal therapeutic efficacy of 
SPNS-DOX in vivo 
To further investigate the advantages of 
SPNS-DOX-GSH in chemo-photothermal cancer 
therapy in vivo, series of animal experiments were 
carried out using different materials. Balb/c mice 
were bilaterally injected in the hind flank with ~2×106 
4T1 cells. After the tumor volume reached about 100 
mm3, the mice were randomly divided into seven 
groups (n = 5 per group). A group of five mice were 
intravenously injected with 200 L of 
SPNS-DOX-GSH at 1.5 mg ml-1 (a dose of 300 g) 
with tumors irradiated by the 808 nm laser for 5 min 
at a low power density of 0.3 W cm-2 at 24 h p.i.. The 
group was denoted as ‘SDG + Laser’. For comparison, 
another group of five mice (denoted as the ‘SG + 
Laser’ group) were injected with SPNS-GSH at the 
same dose (300 g) and exposed to the laser at the 
same conditions as used for ‘SG + Laser’. In addition, 
another group of five mice (denoted as the ‘D + SG + 
Laser’ group) were injected with free DOX (17 g) 
and SPNS-GSH (300 g) and then exposed to the 
laser at the same conditions as used for ‘D + SG + 
Laser’. Four other groups included saline injected 
mice (Control), saline injected mice exposed to laser 
(Laser), free DOX injected mice (denoted as “D”) and 
SPNS-DOX-GSH injected mice without laser 
irradiation (denoted as ‘SDG’), were also used as 
controls. The tumor sizes and mice survival were 
monitored every 2 days after treatments (Fig. 5(a,b)).  
 
Figure 5 Photothermal destruction of tumors in mice using 
intravenously injected SPNS-DOX-GSH. (a) Relative Tumor 
Volume (RTV) of different groups after treatment. The tumor 
volumes were normalized to their initial sizes (n=5 per group). 
(b) Morbility Free Survival (MFS) curves of mice bearing 4T1 
tumor after various treatments indicated. SPNS-DOX-GSH 
injected mice after photothermal therapy survived over 60 days 
without any single death. (c,d) Representative photographs of 
the mice before (c) and after (d) treatment. The laser irradiated 
tumors on SPNS-DOX-GSH injected mice were completely 
destructed.   
As shown in Fig. 5(a), the mice treated only with 
free DOX (17 g) exhibited rapid tumor volume 
increase. indicating that the dosage of administered 
DOX was too low to reduce the tumor volume. On 
the other hand, for the mice treated with 
SPNS-DOX-GSH (‘SDG’ group), the growth of 
tumors was inhibited only within the first four days 
in which slightly reduced tumor volumes were 
observed. However, beyond six days, the recurrence 
of tumor growth was observed with continuously 
increased tumor volume, suggesting that SPNS-GSH 
effectively deliver DOX into tumor but the tumors 
were not completely ablated in the ‘SDG’ group 
treated with only chemotherapy. Similarly, for the 
mice in the ‘SG + Laser’ group, the tumor growth was 
slightly inhibited only in the first two days after 
treatments, suggesting that the irradiation of 808 nm 
laser at 0.3 W cm-2 on SPNS-GSH nanosheets did not 
generate enough heat to ablate the tumor tissues, or 
even suppress their growth. However, All irradiated 
tumors on the mice in the ‘SDG + Laser’ group 
disappeared (Fig. 5(a)), leaving the original tumor 
sites with black scars which fell off in ~2 weeks after 
the treatments (Fig.5(c,d)). No tumor regrowth was 
noted in this treated group over a course of 60 days, 
after which the study was ended. In all the other four 
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groups (i.e., control, Laser, SG + Laser, D + SG + 
Laser), tumors grew rapidly after treatments. 
Interestingly, even the treatment of free DOX + SG + 
Laser can’t effectively ablate tumors, suggesting that 
only the DOX loaded on the surface of SPNS-DOX 
could enhance the accumulation of the photothermal 
agent in the tumors to promote the efficacy of 
photothermal therapy in vivo.  
All the results suggested that the chemotherapy 
and photothermal therapy were successfully 
combined in the SPNS-DOX-GSH nanosystem. The 
system exhibit an obvious synergistic effect that the 
combined DOX and photothermal treatments were 
more cytotoxic than chemotherapy or photothermal 
treatment alone. This synergistic effect was ascribed 
to enhanced cytotoxicity of DOX at elevated 
temperatures [38-40] and a higher accumulation of 
the SPNS-DOX-GSH in the tumor than SPNS-GSH. 
It should be noted that the ‘SDG + Laser’ treatment 
indeed significantly increased the life spans of 
treated mice. The mice in the ‘SDG + Laser’ group 
were tumor-free after the treatment (SPNS-GSH 
injection, NIR laser irradiation) and survived over 60 
days without a single death (Fig. 5(b)), while mice in 
the six control groups showed much shorter life 
spans averaged at 16-22 days. These comprehensive 
studies clearly demonstrated that SPNS-DOX-GSH 
was a powerful agent for combined chemotherapy 
and photothermal cancer therapy in vivo.  
3.6 Clearance properties of SPNS-DOX-GSH in vivo  
As revealed in both in vitro and in vivo studies, a 
significant synergistic effect to enhance both 
chemotherapy of DOX and photothermal therapy of 
Pd nanosheets was readily achieved by loading DOX 
on the photothermal agent, SPNS, the only inorganic 
components in our system, were serving as the NIR 
photothermal agent and the carriers for chemical 
drugs as well. What is also very important in the 
design of our system is that the size of Pd nanosheets 
is thoroughly below the renal filtration threshold (10 
nm). The GSH-modified SPNS could be cleared out 
from bodies through the renal excretion route into 
urine. In this work, we also investigated the clearance 
properties of SPNS-DOX-GSH in vivo. Doses of 300 
g of SPNS-DOX-GSH were intravenously 
administered into male SD rats (n = 3). Urine was 
collected within a 15-day period after administration 
and Pd concentrations were measured by ICP-MS. As 
shown in Fig. 6, more than 7.4% of the 
SPNS-DOX-GSH were excreted out of the body 
within 1 day p.i. and up to 44.3% after 15 day p.i.. To 
assess the systematic toxicity of our combined 
therapeutic agent, mice treated with SPNS-DOX-GSH 
(300 g) were evaluated by pathological 
examinations. Major organs of saline or 
SPNS-DOX-GSH + laser treated mice were collected 
for histology analysis 40 days after treatment. No 
noticeable lesions were observed from HE stained 
organ slices in organs of the treatment group (Fig. S8 
in the ESM). Moreover, during the study, neither 
death nor significant body weight drop was noted in 
the SPNS-DOX-GSH + laser treated group (Fig. S9 in 
the ESM). These results indicated low systematic 
toxicity of SPNS-DOX-GSH in vivo.  
 
Figure 6 In vivo clearance of SPNS-DOX-GSH. Urinary 
cumulative excretion of SPNS-DOX-GSH in rats (n=3) following 
i.v. administration at a single dose of 10 mg kg-1. The amount of 
Pd in urinary samples was measured by ICP-MS. 
4 Conclusions  
In summary, an effective cancer therapeutic 
nanosystem based on plasmonic ultrasmall Pd 
nanosheets was developed. With the Pd nanosheets 
as both the NIR photothermal agent and drug 
carriers for anticancer chemical drug (DOX), the 
developed nanosystem exhibited a significant 
synergistic effect to enhance both chemotherapy of 
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the chemical drugs and the photothermal therapy of 
the drug carriers. In vitro and in vivo studies clearly 
demonstrated that the loading of DOX improved the 
accumulation of Pd nanosheets in tumors and also 
optimized their uptakes by cancer cells. The 
synergistic effect allowed lower the dose of chemical 
drugs and the power of NIR laser for effective 
anticancer therapy. More importantly, due to the 
ultra-small size, the developed Pd-DOX-GSH hybrid 
nanoparticles were readily cleared from body 
through the renal excretion route and into urine. The 
chemo-photothermal therapeutic nanosystem 
demonstrated in this work hold great potentials for 
clinical applications.    
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Materials 
Pd(acac)2 (99%) and N,N-Dimethylpropionamide (DMP) was purchased from Alfa Aesar. PVP (MW=30000, 
AR) and sodium bromide were purchased from Sinopharm Chemical Reagent Co. Ltd. (Shanghai, China). 
Doxorubicin Hydrochloride was purchased from Beijing HuaFeng United Technology CO., Ltd. Male 
Sprague-Dawley rats (220 ± 30 g) and Balb/c mice were purchased from the Shanghai SLAC Laboratory 
Animal Co. Ltd. Human hepatoma cells (QGY-7703) were purchased from cell storeroom of Chinese 
Academy of Science. RPMI 1640 cell culture medium, bovine serum albumin (BSA) and 
Penicillin-Streptomycin compound were purchased from Hyclone Laboratories Inc. MTT was purchased 
from Sigma. The water used in all experiments was ultrapure. All reagents were used as received without 
further purification.  
  
 












Figure S1 Absorption spectra of DOX solution before and after loading on SPNS. 
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Figure S3 The fluorescence spectra of SPNS-DOX. 
 





Figure S4 Micrograph corresponding to in vitro photothermal therapy by SPNS at an optical power density of 1.4 w cm-2. Dead cells 
were stained with Trypan blue. 
 
 
Figure S5 The absorption spectra of SPNS, SPNS-GSH and SPNS-DOX-GSH in FBS. 
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Figure S7 The temperature evolution on tumors of mice with SPNS-GSH, SPNS-DOX-GSH and saline injection. The tumors were 
exposed to the 808 nm laser at a power density of 0.3 W cm-2. 
 
 





Figure S8 Major organs H&E stained images from untreated mice and mice survived after photothermal therapy. Scale bar: 100 μm.  
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